Chemical Compound Review:
LY 127935 disodium 7-[[2-carboxylato-2-(4...
Synonyms:
Shionogi 6059S, AGN-PC-00JSUE, SureCN719333, AG-G-43969, M8158_FLUKA, ...
This record was replaced with 3889.
- Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis. Landesman, S.H., Corrado, M.L., Cherubin, C.C., Gombert, M., Cleri, D. Am. J. Med. (1980)
- Comparative in vitro activities of third-generation cephalosporins. Fass, R.J. Arch. Intern. Med. (1983)
- Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Yu, V.L., Vickers, R.M., Zuravleff, J.J. Antimicrob. Agents Chemother. (1980)
- Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12. Komatsu, Y., Nishikawa, T. Antimicrob. Agents Chemother. (1980)
- LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity. Trager, G.M., White, G.W., Zimelis, V.M., Panwalker, A.P. Antimicrob. Agents Chemother. (1979)
- Gram-negative bacillary meningitis. New therapy and changing concepts. Landesman, S.H., Cherubin, C.E., Corrado, M.L. Arch. Intern. Med. (1982)
- The concentration of latamoxef achieved in the bile and gallbladder wall of patients with cholecystitis. Vowden, P., Stewart, J., Fowler, B., Ramsden, C.H., Kester, R.C. J. Antimicrob. Chemother. (1986)
- The activity in vitro of ceftazidime (GR 20263) and moxalactam (LY 127935) against Gram-negative bacteria from hospital patients. Pedler, S.J. J. Antimicrob. Chemother. (1981)
- Structural requirements for antibacterial activity and beta-lactamase stability of 7 beta-arylmalonylamino-7 alpha-methoxy-1-oxacephems. Yoshida, T. Philos. Trans. R. Soc. Lond., B, Biol. Sci. (1980)
- Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin. Watanakunakorn, C., Glotzbecker, C. J. Antibiot. (1979)
- Straightforward synthesis of 7 alpha-methoxy-1-oxacephems from penicillins. Nagata, W. Philos. Trans. R. Soc. Lond., B, Biol. Sci. (1980)
- A high incidence of bleeding is observed in a trial to determine whether addition of metronidazole is needed with latamoxef for prophylaxis in colorectal surgery. Morris, D.L., Fabricius, P.J., Ambrose, N.S., Scammell, B., Burdon, D.W., Keighley, M.R. J. Hosp. Infect. (1984)
- Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse. Pusztai-Markos, Z., Pranada, F., Leimbrock, C. Chemotherapy. (1982)
- Improvement of the rectal bioavailability of latamoxef sodium by adjuvants following administration of a suppository. Nakanishi, K., Masukawa, T., Masada, M., Nadai, T. Biol. Pharm. Bull. (1994)
- Evaluation of moxalactam. Reed, M.D., Bertino, J.S., Aronoff, S.C., Speck, W.T., Blumer, J.L. Clinical pharmacy. (1982)
- Transcervical amnioinfusion of antibiotics: a basic study for managing premature rupture of membranes. Ogita, S., Imanaka, M., Matsumoto, M., Oka, T., Sugawa, T. Am. J. Obstet. Gynecol. (1988)
- Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam). Hautmann, R., Pranada, F., Ahlert, G. International journal of clinical pharmacology, therapy, and toxicology. (1983)
- Evaluation of pharmacy and therapeutics committee drug evaluation reports. Majercik, P.L., May, J.R., Longe, R.L., Johnson, M.H. American journal of hospital pharmacy. (1985)
- Moxalactam concentration in human aqueous humor after intravenous administration. Axelrod, J.L., Kochman, R.S. Arch. Ophthalmol. (1982)
- High-performance liquid chromatographic analysis of a new beta-lactam antibiotic, 6059-S (moxalactam). Konaka, R., Kuruma, K., Nishimura, R., Kimura, Y., Yoshida, T. J. Chromatogr. (1981)